BNTX

The vaccine was also found to be safe and well-tolerated among the children in the study, the companies said Monday. Many of the children had received at least some of their shots during the Omicron wave, suggesting that the three-dose series worked well against the highly contagious variant after the two doses produced mixed results. “We have a big problem called Omicron, and I think we have a good solution,” Pfizer Chief Executive Albert Bourla said in an interview.…

An outside panel of experts for the Centers for Disease Control and Prevention on Thursday is scheduled to weigh whether children ages 5 to 11 should receive the newly authorized Covid-19 booster shot from Pfizer Inc. and BioNTech SE.The panel’s recommendations would guide the nation’s doctors, schools and local policy makers in what vaccine advice they give to parents of the 28 million U.S. children in the age group. The Food and Drug Administration earlier this…

U.S. health regulators cleared for use a booster shot of the Covid-19 vaccine from Pfizer Inc. and BioNTech SE for children 5 to 11 years, expanding booster access to about 28 million youngsters. The decision Tuesday by the U.S. Food and Drug Administration permits a third dose of the shot at least five months after the second dose. It comes weeks after the drugmakers said a third shot safely generated a strong immune response in the children, including…